USPTO serial 78090582
INOXELL
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- HAYASH, SUSAN C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INOXELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
2970 Hørsholm, DK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Clarke Weber
CYNTHIA CLARKE WEBER SUGHRUE MION PLLC2100 PENNSYLVANIA AVE NWWASHINGTON, DC 20037-3202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products, including biochemical products, namely, proteins, peptides, polypeptides, nucleic acids, and molecular biological vectors for scientific, diagnostic, therapeutic and research laboratory use; chemical preparations, namely, biochemical preparations for laboratory analyses, for diagnostic and therapeutic use and for in vivo analyses in life science research; biochemicals and biomedicals, namely, proteins, polypeptides, peptides, nucleic acids, molecular biological vectors, including retrovirus, adenovirus and vaccinia virus vectors all for scientific, research laboratory, diagnostic and therapeutic use; biological and biochemical libraries used as scientific, therapeutic, diagnostic and research laboratory reagents, including DNA and peptide libraries; recombinant cell lines, including packaging cells for use in preparation of retrovirus used as reagents for scientific and research purposes; chemical products for use in the development of pharmaceuticals, drug targets, and drug leads for medical science | ACTIVE | — |
| 005 | Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders; infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; chemical preparations, namely, biochemical preparations for laboratory analyses, for diagnostic and therapeutic use and for in vivo analyses in medical science research; biochemicals, namely, proteins, polypeptides, peptides and nucleic acids, all of the aforesaid goods for medical, diagnostic, therapeutic or veterinary purposes; molecular biological vectors, including retrovirus, adenovirus, and vaccinia virus vectors, all of the aforesaid goods for medical, diagnostic, therapeutic or veterinary purposes; biological and biochemical libraries, used as medical, diagnostic, therapeutic or veterinary reagents, including DNA and peptide libraries, the aforesaid goods for medical, diagnostic, therapeutic and veterinary use; recombinant cell lines, including packaging cells for use in preparation of retrovirus used as reagents for medical and veterinary purposes | ACTIVE | — |
| 042 | Scientific, industrial, biotechnological and biomedical research; development and identification of pharmaceutical preparations drug leads; chemical, biochemical and molecular biological analyses; medical and scientific research, namely, in vivo and in vitro preclinical testing of drug leads; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 25, 2002 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Oct 23, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2002 | PAPER RECEIVED | — | |
| May 1, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 1, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 29, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2002 | DOCK | ASSIGNED TO EXAMINER | — |